Bios Partners

Bios Partners investment thesis

Home Thesis Team Portfolio Development Contact Bios Investment Thesis Bios Investment Thesis Is Based On Three Pillars. Bios Investment Thesis: Part 1 Disrupting The Geographic Favoritism Bios identified a dearth of venture funding in the Central United States, where an abundance of innovative science is being continually developed. For example, there is a void in VC funding outside of Silicon Valley and the Northeastern US, where the NIH (National Institute of Health) funds $3.36 per every $1 of venture capital in the Central US. Compare this to $0.57 in the Western US and $0.68 in the Northeastern US of NIH funding for every $1 of VC funding. Given that the NIH is an unbiased source of funding and validation of technology, we believe this dynamic demonstrates the abundance of underfunded

Bios Partners team (10)

Partners and principals at Bios Partners:

• Patrick Browning — sweet spot $1.5M
• Amanda De La Garza — sweet spot $1.5M
• Aaron G.L. Fletcher — sweet spot $1.5M
• John Fucci — sweet spot $1.5M
• Steven Hood — sweet spot $1.5M
• Roni Meintjes — sweet spot $1.5M
• Blake Pate — sweet spot $1.5M
• Stella Robertson — sweet spot $1.5M
• Tim Van Treuren — sweet spot $1.5M
• Travis Whitfill — sweet spot $1.5M

Bios Partners portfolio companies

Companies listed on Bios Partners's public materials include: Thesis, Team, Portfolio, Development, Portfolio Companies, Acquired/Exited Portfolio Companies, Top.

Is Bios Partners a fit for your round?

Upload your pitch deck and see whether anyone at Bios Partners appears in your top matches.